Skip to main content
. 2020 Jun 30;4(4):1–5. doi: 10.1093/ehjcr/ytaa205
Date Events
2004 Diagnosed with dilated cardiomyopathy.
From 2004 to 2015 More than 20 hospitalizations for exacerbation of chronic heart failure (HF) with a progressive reduction of the ejection fraction (EF).
2015 Balloon angioplasty and stent implantation in circumflex (Cx) artery. Biventricular implantable cardioverter-defibrillator implantation for primary prevention.
September 2017 MitraClip placement for a severe functional mitral regurgitation.
October 2017 First access to our departmental HF Clinic.
From October 2017 to May 2019 The patient went through numerous exacerbations, despite optimal medical therapy.
May 2019 Evidence of reduced EF (20%) and decision to start cyclic levosimendan infusion.
June 2019 CardioMEMS implantation.
September 2019 Scheduled hospitalization for levosimendan infusion.
December 2019 Scheduled hospitalization for levosimendan infusion.
From December 2019 to February 2020 After December 2019, the cardiologist continued to monitor the patient, making therapy adjustments according to diastolic PA pressure. No further levosimendan infusions were made between December 2019 and February 2020.